Skip to content
Life Sciences Series B Founded 2016

Monarch Bioimplants

Developer of bioimplant for peripheral nerve repair

📍 Root, Switzerland · Neurology

Funding snapshot

Last roundSeries B
Amount$23M
Date28 September 2020

About

Developer of bioimplant for peripheral nerve repair. The company has a NeuroShield device that provides non-constricting protection for the nervous system. It is made of naturally occurring Chitosan which shields nerves from further damage and promotes faster regrowth.

Latest news

No articles yet.

Raising like Monarch Bioimplants?

Analyze your pitch deck before your next raise.

Analyze My Deck →